| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |